Immunex Subscribes to Celera Database | GenomeWeb

Celera Genomics said Immunex had purchased 5-year subscriptions to several of its genomic databases.


Details of the transaction were not disclosed, but earlier subscribers to Celera’s databases have reportedly paid between $25 million and $50 million for three- to five-year periods.


Based in Seattle, Immunex markets the arthritis drug Enbrel.


Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.